ID28280A - BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2 - Google Patents

BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2

Info

Publication number: ID28280A
Authority: ID; Indonesia
Prior art keywords: benzotienol; antagonists; pyridine
Prior art date: 1998-10-06

Application number

IDW20010781A

Other languages

English (en)

Inventor

L E J Kennis

S M A Pieters

F P Bischoff

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-06

Filing date

1999-10-01

Publication date

2001-05-10

1999-10-01 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2001-05-10 Publication of ID28280A publication Critical patent/ID28280A/id

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IDW20010781A 1998-10-06 1999-10-01 BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2 ID28280A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98203363		1998-10-06

Publications (1)

Publication Number	Publication Date
ID28280A true ID28280A (id)	2001-05-10

Family

ID=8234188

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010781A ID28280A (id)	1998-10-06	1999-10-01	BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2

Country Status (27)

Country	Link
US (2)	US6426350B1 (id)
EP (1)	EP1117667B1 (id)
JP (1)	JP4580555B2 (id)
KR (1)	KR20010071828A (id)
CN (1)	CN1158287C (id)
AR (1)	AR023678A1 (id)
AT (1)	ATE363485T1 (id)
AU (1)	AU760226B2 (id)
BG (1)	BG64625B1 (id)
BR (1)	BR9913110A (id)
CA (1)	CA2346084C (id)
CZ (1)	CZ20011103A3 (id)
DE (1)	DE69936219T2 (id)
EE (1)	EE04835B1 (id)
ES (1)	ES2288025T3 (id)
HU (1)	HUP0103612A3 (id)
ID (1)	ID28280A (id)
IL (2)	IL142442A0 (id)
NO (1)	NO20011309L (id)
NZ (1)	NZ509911A (id)
PL (1)	PL347184A1 (id)
RU (1)	RU2222542C2 (id)
SK (1)	SK4312001A3 (id)
TR (1)	TR200100954T2 (id)
TW (1)	TWI251595B (id)
UA (1)	UA70334C2 (id)
WO (1)	WO2000020422A1 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2305284A3 (en) *	2002-03-08	2012-11-14	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Use of EGFR transactivation inhibitors in human cancer
ATE521593T1 (de) *	2002-04-03	2011-09-15	Orion Corp	Verwendung eines alfa2-adrenorezeptorantagonisten bei mit dem zns zusammenhängenden erkrankungen
AU2005233456A1 (en)	2004-04-12	2005-10-27	Taisho Pharmaceutical Co., Ltd.	Cyclic amine compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3752820A (en)	1972-03-20	1973-08-14	Colgate Palmolive Co	Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr)	1984-09-27	1987-05-22	Synthelabo	Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) *	1985-09-03	1987-08-11	Merck & Co., Inc.	Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4985422A (en) *	1988-04-27	1991-01-15	Glaxo Group Limited	Lactam derivatives
US5100891A (en) *	1991-01-18	1992-03-31	Hoechst-Roussel Pharmaceuticals Inc.	Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
GB9106179D0 (en) *	1991-03-22	1991-05-08	Sandoz Ltd	Improvements in or relating to organic compounds
ES2204932T3 (es) *	1994-09-12	2004-05-01	Eli Lilly And Company Limited	Moduladores serotonergicos.
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤
UA52681C2 (uk)	1997-04-08	2003-01-15	Янссен Фармацевтика Н.В.	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

1999
- 1999-01-10 UA UA2001031998A patent/UA70334C2/uk unknown
- 1999-10-01 EE EEP200100206A patent/EE04835B1/xx not_active IP Right Cessation
- 1999-10-01 CZ CZ20011103A patent/CZ20011103A3/cs unknown
- 1999-10-01 WO PCT/EP1999/007418 patent/WO2000020422A1/en not_active Ceased
- 1999-10-01 IL IL14244299A patent/IL142442A0/xx active IP Right Grant
- 1999-10-01 ES ES99947469T patent/ES2288025T3/es not_active Expired - Lifetime
- 1999-10-01 CA CA2346084A patent/CA2346084C/en not_active Expired - Fee Related
- 1999-10-01 RU RU2001111753/04A patent/RU2222542C2/ru not_active IP Right Cessation
- 1999-10-01 HU HU0103612A patent/HUP0103612A3/hu unknown
- 1999-10-01 JP JP2000574534A patent/JP4580555B2/ja not_active Expired - Fee Related
- 1999-10-01 PL PL99347184A patent/PL347184A1/xx not_active Application Discontinuation
- 1999-10-01 BR BR9913110-2A patent/BR9913110A/pt not_active Application Discontinuation
- 1999-10-01 CN CNB998116777A patent/CN1158287C/zh not_active Expired - Fee Related
- 1999-10-01 AT AT99947469T patent/ATE363485T1/de not_active IP Right Cessation
- 1999-10-01 TW TW088116899A patent/TWI251595B/zh not_active IP Right Cessation
- 1999-10-01 TR TR2001/00954T patent/TR200100954T2/xx unknown
- 1999-10-01 AU AU60899/99A patent/AU760226B2/en not_active Ceased
- 1999-10-01 KR KR1020017000400A patent/KR20010071828A/ko not_active Ceased
- 1999-10-01 DE DE69936219T patent/DE69936219T2/de not_active Expired - Lifetime
- 1999-10-01 SK SK431-2001A patent/SK4312001A3/sk unknown
- 1999-10-01 ID IDW20010781A patent/ID28280A/id unknown
- 1999-10-01 US US09/806,432 patent/US6426350B1/en not_active Expired - Lifetime
- 1999-10-01 NZ NZ509911A patent/NZ509911A/xx unknown
- 1999-10-01 EP EP99947469A patent/EP1117667B1/en not_active Expired - Lifetime
- 1999-10-05 AR ARP990105039A patent/AR023678A1/es active IP Right Grant
2001
- 2001-03-12 BG BG105331A patent/BG64625B1/bg unknown
- 2001-03-15 NO NO20011309A patent/NO20011309L/no not_active Application Discontinuation
- 2001-04-04 IL IL142442A patent/IL142442A/en not_active IP Right Cessation
2002
- 2002-04-16 US US10/123,338 patent/US6774129B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EE04835B1 (et)	2007-06-15
BR9913110A (pt)	2001-05-08
BG64625B1 (bg)	2005-09-30
IL142442A0 (en)	2002-03-10
EE200100206A (et)	2002-06-17
RU2222542C2 (ru)	2004-01-27
ATE363485T1 (de)	2007-06-15
CA2346084A1 (en)	2000-04-13
ES2288025T3 (es)	2007-12-16
CN1158287C (zh)	2004-07-21
CA2346084C (en)	2010-01-26
AU6089999A (en)	2000-04-26
AU760226B2 (en)	2003-05-08
EP1117667A1 (en)	2001-07-25
NO20011309D0 (no)	2001-03-15
HK1039113A1 (en)	2002-04-12
NO20011309L (no)	2001-03-15
TWI251595B (en)	2006-03-21
IL142442A (en)	2006-10-05
TR200100954T2 (tr)	2001-12-21
US6774129B2 (en)	2004-08-10
BG105331A (en)	2001-11-30
NZ509911A (en)	2002-09-27
JP2002526546A (ja)	2002-08-20
US6426350B1 (en)	2002-07-30
EP1117667B1 (en)	2007-05-30
KR20010071828A (ko)	2001-07-31
UA70334C2 (en)	2004-10-15
JP4580555B2 (ja)	2010-11-17
DE69936219D1 (de)	2007-07-12
WO2000020422A1 (en)	2000-04-13
CN1321159A (zh)	2001-11-07
HUP0103612A2 (hu)	2002-01-28
HUP0103612A3 (en)	2003-03-28
DE69936219T2 (de)	2008-02-07
AR023678A1 (es)	2002-09-04
PL347184A1 (en)	2002-03-25
US20020169178A1 (en)	2002-11-14
SK4312001A3 (en)	2001-12-03
CZ20011103A3 (cs)	2001-12-12

Publication	Publication Date	Title
CU23053A3 (es)	2005-06-24	1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
ID18003A (id)	1998-02-19	Antagonis muskarinik
PT1087971E (pt)	2004-10-29	Compostos de pirrolo[2,3-d]piridina
ATE312819T1 (de)	2005-12-15	4,4-biarylpiperidinederivate mit opioid-receptor- wirkung
ID19623A (id)	1998-07-23	Antagonis reseptor vitronektin
ATE240327T1 (de)	2003-05-15	1,2-annelierte chinolinderivate
PL367064A1 (en)	2005-02-21	Dihydro-benzo [b] [1,4] diazepin-2-one derivatives as mglur2 antagonists ii
ID26698A (id)	2001-02-01	SENYAWA-SENYAWA PIROLO [2,3-d] PIRIMIDINA
DK1000048T3 (da)	2003-03-03	Substituerede 1,2,3,4-tetrahydronapthalenderivater
IS5815A (is)	2001-01-16	Setin 1,8-naftýridín-4(1H)-ón sem fosfódíesterasa4 latar
PL367086A1 (en)	2005-02-21	Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i
ID26223A (id)	2000-12-07	Antagonis reseptor vitronektin
ID26665A (id)	2001-01-25	Antagonis vla-4
NO990859L (no)	1999-09-30	1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater
NO20003825D0 (no)	2000-07-26	1,3,4 - oxadiazolonderivater
ID27845A (id)	2001-04-26	Turunan tetrahidrokuilina sebagai antagonis glisilina
ID28811A (id)	2001-07-05	Antagonis reseptor vitronektin
ID24468A (id)	2000-07-20	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
EP0986553A4 (en)	2000-12-27	DIHYDROPYRIMIDONE DERIVATIVES AS NPY ANTAGONISTS
ID30484A (id)	2001-12-13	Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin
NO20004807L (no)	2000-11-24	3´,3´-N-bis-substituerte makrolid LHRH antagonister
ID28280A (id)	2001-05-10	BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2
ID24309A (id)	2000-07-13	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
EP1156040A4 (en)	2002-03-20	2,4-dioxo-5-ARYLIDENIMIDO-1,3-pyrimidines
PT1010699E (pt)	2005-08-31	Derivados de 3-oxadiazolil-1,6-naftiridina-2(h)-ona substituido em 5